Literature DB >> 24795840

PET brain kinetics studies of (11)C-ITMM and (11)C-ITDM,radioprobes for metabotropic glutamate receptor type 1, in a nonhuman primate.

Tomoteru Yamasaki1, Jun Maeda2, Masayuki Fujinaga1, Yuji Nagai2, Akiko Hatori1, Joji Yui1, Lin Xie1, Nobuki Nengaki3, Ming-Rong Zhang1.   

Abstract

The metabotropic glutamate receptor type 1 (mGluR1) is a novel target protein for the development of new drugs against central nervous system disorders. Recently, we have developed (11)C-labeled PET probes (11)C-ITMM and (11)C-ITDM, which demonstrate similar profiles, for imaging of mGluR1. In the present study, we compared (11)C-ITMM and (11)C-ITDM PET imaging and quantitative analysis in the monkey brain. Respective PET images showed similar distribution of uptake in the cerebellum, thalamus, and cingulate cortex. Slightly higher uptake was detected with (11)C-ITDM than with (11)C-ITMM. For the kinetic analysis using the two-tissue compartment model (2-TCM), the distribution volume (VT) in the cerebellum, an mGluR1-rich region in the brain, was 2.5 mL∙cm(-3) for (11)C-ITMM and 3.6 mL∙cm(-3) for (11)C-ITDM. By contrast, the VT in the pons, a region with negligible mGluR1 expression, was similarly low for both radiopharmaceuticals. Based on these results, we performed noninvasive PET quantitative analysis with general reference tissue models using the time-activity curve of the pons as a reference region. We confirmed the relationship and differences between the reference tissue models and 2-TCM using correlational scatter plots and Bland-Altman plots analyses. Although the scattergrams of both radiopharmaceuticals showed over- or underestimations of reference tissue model-based the binding potentials against 2-TCM, there were no significant differences between the two kinetic analysis models. In conclusion, we first demonstrated the potentials of (11)C-ITMM and (11)C-ITDM for noninvasive PET quantitative analysis using reference tissue models. In addition, our findings suggest that (11)C-ITDM may be superior to (11)C-ITMM as a PET probe for imaging of mGluR1, because regional VT values in PET with (11)C-ITDM were higher than those of (11)C-ITMM. Clinical studies of (11)C-ITDM in humans will be necessary in the future.

Entities:  

Keywords:  Central nervous system (CNS); metabotropic glutamate receptor type 1 (mGluR1); positron emission tomography (PET)

Year:  2014        PMID: 24795840      PMCID: PMC3999406     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  37 in total

1.  Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission.

Authors:  G Battaglia; V Bruno; A Pisani; D Centonze; M V Catania; P Calabresi; F Nicoletti
Journal:  Mol Cell Neurosci       Date:  2001-06       Impact factor: 4.314

2.  Sensitive measurement of positron emitters eluted from HPLC.

Authors:  M Takei; T Kida; K Suzuki
Journal:  Appl Radiat Isot       Date:  2001-08       Impact factor: 1.513

3.  Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones.

Authors:  A Pisani; P Calabresi; D Centonze; G Bernardi
Journal:  Br J Pharmacol       Date:  1997-03       Impact factor: 8.739

Review 4.  Distinct physiological roles of the Gq-coupled metabotropic glutamate receptors Co-expressed in the same neuronal populations.

Authors:  Ornella Valenti; P Jeffrey Conn; Michael J Marino
Journal:  J Cell Physiol       Date:  2002-05       Impact factor: 6.384

5.  Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain.

Authors:  Masanori Ichise; Jeih-San Liow; Jian-Qiang Lu; Akihiro Takano; Kendra Model; Hiroshi Toyama; Tetsuya Suhara; Kazutoshi Suzuki; Robert B Innis; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2003-09       Impact factor: 6.200

6.  Down-regulation of metabotropic glutamate receptor 1alpha in globus pallidus and substantia nigra of parkinsonian monkeys.

Authors:  K Kaneda; Y Tachibana; M Imanishi; H Kita; R Shigemoto; A Nambu; M Takada
Journal:  Eur J Neurosci       Date:  2005-12       Impact factor: 3.386

7.  Imaging for metabotropic glutamate receptor subtype 1 in rat and monkey brains using PET with [18F]FITM.

Authors:  Tomoteru Yamasaki; Masayuki Fujinaga; Jun Maeda; Kazunori Kawamura; Joji Yui; Akiko Hatori; Yuichiro Yoshida; Yuji Nagai; Masaki Tokunaga; Makoto Higuchi; Tetsuya Suhara; Toshimitsu Fukumura; Ming-Rong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-24       Impact factor: 9.236

8.  Characterization of 1-(2-[18F] fluoro-3-pyridyl)-4-(2-isopropyl-1-oxo- isoindoline-5-yl)-5-methyl-1H-1,2,3-triazole, a PET ligand for imaging the metabotropic glutamate receptor type 1 in rat and monkey brains.

Authors:  Masayuki Fujinaga; Jun Maeda; Joji Yui; Akiko Hatori; Tomoteru Yamasaki; Kazunori Kawamura; Katsushi Kumata; Yuichiro Yoshida; Yuji Nagai; Makoto Higuchi; Tetsuya Suhara; Toshimitsu Fukumura; Ming-Rong Zhang
Journal:  J Neurochem       Date:  2011-07-01       Impact factor: 5.372

9.  Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency.

Authors:  P L Pearl; K M Gibson; Z Quezado; I Dustin; J Taylor; S Trzcinski; J Schreiber; K Forester; P Reeves-Tyer; C Liew; S Shamim; P Herscovitch; R Carson; J Butman; C Jakobs; W Theodore
Journal:  Neurology       Date:  2009-08-11       Impact factor: 9.910

10.  The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death.

Authors:  Flavio Moroni; Sabina Attucci; Andrea Cozzi; Elena Meli; Roberta Picca; Mark A Scheideler; Roberto Pellicciari; Christian Noe; Iran Sarichelou; Domenico E Pellegrini-Giampietro
Journal:  Neuropharmacology       Date:  2002-05       Impact factor: 5.250

View more
  10 in total

1.  [carbonyl-11C]4-Fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([11C]FIMX) is an effective radioligand for PET imaging of metabotropic glutamate receptor 1 (mGluR1) in monkey brain.

Authors:  Jinsoo Hong; Shuiyu Lu; Rong Xu; Jeih-San Liow; Alicia E Woock; Kimberly J Jenko; Robert L Gladding; Sami S Zoghbi; Robert B Innis; Victor W Pike
Journal:  Nucl Med Biol       Date:  2015-07-23       Impact factor: 2.408

2.  Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject.

Authors:  Hui Liu; Hongjun Jin; Xuyi Yue; Xiang Zhang; Hao Yang; Junfeng Li; Hubert Flores; Yi Su; Joel S Perlmutter; Zhude Tu
Journal:  Neuroimage       Date:  2015-07-26       Impact factor: 6.556

3.  Relationship between type 1 metabotropic glutamate receptors and cerebellar ataxia.

Authors:  Kenji Ishibashi; Yoshiharu Miura; Kinya Ishikawa; Ming-Rong Zhang; Jun Toyohara; Kiichi Ishiwata; Kenji Ishii
Journal:  J Neurol       Date:  2016-08-08       Impact factor: 4.849

4.  Improved Visualization and Specific Binding for Metabotropic Glutamate Receptor Subtype 1 (mGluR1) Using [11C]ITMM with Ultra-High Specific Activity in Small-Animal PET.

Authors:  Tomoteru Yamasaki; Masayuki Fujinaga; Joji Yui; Hidekatsu Wakizaka; Tomoyuki Ohya; Nobuki Nengaki; Masanao Ogawa; Yoko Ikoma; Akiko Hatori; Lin Xie; Kazunori Kawamura; Ming-Rong Zhang
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

Review 5.  Development of PET and SPECT probes for glutamate receptors.

Authors:  Takeshi Fuchigami; Morio Nakayama; Sakura Yoshida
Journal:  ScientificWorldJournal       Date:  2015-03-22

6.  In Vivo Monitoring for Regional Changes of Metabotropic Glutamate Receptor Subtype 1 (mGluR1) in Pilocarpine-Induced Epileptic Rat Brain by Small-Animal PET.

Authors:  Tomoteru Yamasaki; Masayuki Fujinaga; Wakana Mori; Yiding Zhang; Hidekatsu Wakizaka; Nobuki Nengaki; Lin Xie; Akiko Hatori; Ming-Rong Zhang
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

7.  Revisiting the Logan plot to account for non-negligible blood volume in brain tissue.

Authors:  Martin Schain; Patrik Fazio; Ladislav Mrzljak; Nahid Amini; Nabil Al-Tawil; Cheryl Fitzer-Attas; Juliana Bronzova; Bernhard Landwehrmeyer; Christina Sampaio; Christer Halldin; Andrea Varrone
Journal:  EJNMMI Res       Date:  2017-08-18       Impact factor: 3.138

8.  Unchanged type 1 metabotropic glutamate receptor availability in patients with Alzheimer's disease: A study using 11C-ITMM positron emission tomography.

Authors:  Kenji Ishibashi; Yoshiharu Miura; Jun Toyohara; Kiichi Ishiwata; Kenji Ishii
Journal:  Neuroimage Clin       Date:  2019-03-16       Impact factor: 4.881

9.  In vitro and In vivo Assessment of Suitable Reference Region and Kinetic Modelling for the mGluR1 Radioligand [11C]ITDM in Mice.

Authors:  Daniele Bertoglio; Jeroen Verhaeghe; Špela Korat; Alan Miranda; Leonie Wyffels; Sigrid Stroobants; Ladislav Mrzljak; Celia Dominguez; Longbin Liu; Mette Skinbjerg; Ignacio Munoz-Sanjuan; Steven Staelens
Journal:  Mol Imaging Biol       Date:  2020-08       Impact factor: 3.488

Review 10.  A Review of Molecular Imaging of Glutamate Receptors.

Authors:  Jong-Hoon Kim; János Marton; Simon Mensah Ametamey; Paul Cumming
Journal:  Molecules       Date:  2020-10-16       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.